Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Century Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +28 vs. Q1 2026
- Shares held
- 158.0M
- +17.9M (+12.7%) vs. Q1 2026
- Total value
- $387.0M
- +$71.4M (+22.6%) vs. Q1 2026
- New holders
- 38
- 28 more added
- Sold out
- 10
- 12 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Syncona Portfolio Ltd | 0 | $0 | 0.00% | −1,213,056−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −278,075−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −119,308−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −96,641−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −49,000−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −47,800−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −22,518−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,028−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −407−100.0% | Sold out |